🇺🇸 Antiretroviral therapy in United States

32 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Resistance — 7 reports (21.88%)
  2. Syncope — 4 reports (12.5%)
  3. Drug Interaction — 3 reports (9.38%)
  4. Electrocardiogram Qt Prolonged — 3 reports (9.38%)
  5. Pyrexia — 3 reports (9.38%)
  6. Torsade De Pointes — 3 reports (9.38%)
  7. Treatment Noncompliance — 3 reports (9.38%)
  8. Acute Myocardial Infarction — 2 reports (6.25%)
  9. Anaemia — 2 reports (6.25%)
  10. Asthenia — 2 reports (6.25%)

Source database →

Other Infectious Disease / Virology approved in United States

Frequently asked questions

Is Antiretroviral therapy approved in United States?

Antiretroviral therapy does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Antiretroviral therapy in United States?

ANRS, Emerging Infectious Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.